Hexagon Nutrition IPO GMP Day 1 on 5 June 2026: Rs 10 Grey Market Premium Points to 22% Expected Listing Gain on BSE and NSE
- June 5, 2026
- Posted by: Ankit Jaiswal
- Category: IPO
Hexagon Nutrition IPO GMP Day 1 (June 5): Rs 10/share. Expected listing Rs 55 (+22.2%). Price Rs 42-45. Issue Rs 138.87 Cr OFS. Min invest Rs 14,985. Listing Jun 12 BSE+NSE.
The Hexagon Nutrition IPO GMP is grabbing the attention of IPO investors on 5 June 2026, as the Day 1 of the public issue shows Day 1 retail and institutional activity beginning on BSE and NSE platforms.
Hexagon Nutrition Limited, founded in 1993, is one of India’s leading nutritional ingredients and fortified food products companies. The Hexagon Nutrition IPO is backed by a company with over 30 years of experience in the nutritional space, serving B2B customers including food manufacturers, pharmaceutical companies, dairy processors, and institutional nutrition programmes such as mid-day meal schemes and anganwadi nutrition supply chains. The company’s product portfolio includes micronutrient premixes, spray-dried ingredients, and fortified food ingredients. The Hexagon Nutrition IPO GMP reflects investor interest in India’s growing nutritional supplementation and fortified foods segment.
The grey market premium (GMP) for Hexagon Nutrition IPO GMP is currently Rs 10 per share, indicating an expected listing price of approximately Rs 55 against the upper price band of Rs 42 to Rs 45 per share per share, implying a potential listing gain of approximately 22.2%.
Investors must note that grey market premium is an unofficial, unregulated indicator that is not governed by SEBI. GMP fluctuates daily based on investor sentiment, subscription data, and broader market conditions. The Hexagon Nutrition IPO GMP grey market premium should be used as one data point. Investors tracking the Hexagon Nutrition IPO GMP among many in the investment decision process, not as the primary factor. Investors should review the full prospectus before applying for the Hexagon Nutrition IPO GMP. This does not constitute investment advice.
Click Here – Get Free Investment Predictions
Hexagon Nutrition IPO GMP: Key IPO Details on 5 June 2026
| Parameter | Details |
|---|---|
| Company | Hexagon Nutrition Limited |
| Issue Type | Book-built, 100% Offer for Sale (OFS) of 3,08,59,704 shares |
| Exchange | BSE and NSE (Mainboard) |
| Issue Size | Rs 138.87 crore (100% Offer for Sale) |
| Price Band / Issue Price | Rs 42 to Rs 45 per share |
| Face Value | Rs 1 per share |
| Lot Size | 333 shares (1 lot for retail) |
| Minimum Investment | Rs 14,985 (retail, 1 lot at Rs 45) |
| Open Date | June 5, 2026 |
| Close Date | June 9, 2026 |
| Allotment Date | June 10, 2026 |
| Listing Date | June 12, 2026 (BSE and NSE) |
| Issue Structure | 100% OFS of 3.08 crore equity shares by selling shareholders |
| Book Running Lead Manager | Cumulative Capital Pvt Ltd and Catalyst Capital Partners Pvt Ltd |
| Registrar | KFin Technologies Limited |
| GMP (5 June 2026) | Rs 10 per share |
| Expected Listing Price | ~Rs 55 |
| Expected Listing Gain | ~22.2% above issue price |
Check Live IPO Subscription and Allotment on Univest
Track all open IPOs, subscription rates, GMP trends and allotment status in real time.
- Live GMP and subscription data for all open IPOs
- Allotment status checker and listing day alerts
- IPO research and expert analysis on every issue
Access IPO research and insights on Univest
What Is Hexagon Nutrition Limited and What Does It Do?
Hexagon Nutrition Limited, founded in 1993, is one of India’s leading nutritional ingredients and fortified food products companies. The Hexagon Nutrition IPO is backed by a company with over 30 years of experience in the nutritional space, serving B2B customers including food manufacturers, pharmaceutical companies, dairy processors, and institutional nutrition programmes such as mid-day meal schemes and anganwadi nutrition supply chains. The company’s product portfolio includes micronutrient premixes, spray-dried ingredients, and fortified food ingredients. The Hexagon Nutrition IPO GMP reflects investor interest in India’s growing nutritional supplementation and fortified foods segment.
Hexagon Nutrition IPO GMP: Financial Performance
Hexagon Nutrition’s financial profile supports the Hexagon Nutrition IPO GMP sentiment. Revenue grew from Rs 304.62 crore in FY24 to Rs 331.29 crore in FY25, a growth of approximately 8.7% year-on-year. More importantly, FY25 profit after tax grew from Rs 12.21 crore to Rs 24.38 crore, a 99.7% increase that demonstrates significant operating leverage in the business. The Hexagon Nutrition IPO market capitalisation at the upper price band of Rs 45 stands at approximately Rs 553.13 crore. Pre-IPO, promoters held 89.41% of the company; post-IPO this will reduce to approximately 64.29%, creating meaningful public float on BSE and NSE.
Hexagon Nutrition IPO GMP: Use of IPO Proceeds
Since the Hexagon Nutrition IPO is structured entirely as an Offer for Sale (OFS), all proceeds from the Hexagon Nutrition IPO will go to the selling shareholders and not to the company. The company will not receive any funds from the Hexagon Nutrition IPO. This means the OFS proceeds represent an exit or monetisation opportunity for the existing shareholders rather than a fresh capital infusion for the company’s growth. Investors evaluating the Hexagon Nutrition IPO should note this structure when assessing the issuer’s immediate post-IPO financial position.
Hexagon Nutrition IPO GMP: Promoters and Shareholding
The Hexagon Nutrition IPO promoters are Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Vikram Arun Kelkar, and Nikhil Arun Kelkar. Pre-IPO, the promoter group collectively held 89.41% of the company’s equity. Post-IPO, the promoter holding will reduce to approximately 64.29%, as the OFS represents a partial exit by the selling shareholders. The promoter family has operated Hexagon Nutrition for over three decades, providing significant management continuity and domain expertise in the nutritional ingredients industry.
Key Risks to the Hexagon Nutrition IPO GMP
Key risks to the Hexagon Nutrition IPO include: the 100% OFS structure means no fresh capital for company growth; promoter-driven exit creates potential overhang if further stake sales follow post-lock-in expiry; moderate revenue growth of 8.7% in FY25 suggests a mature rather than high-growth business; competition from global nutritional ingredient players could compress margins; and dependence on government nutrition procurement programmes creates revenue volatility. The Hexagon Nutrition IPO GMP of Rs 10 suggests moderate listing upside but is not guaranteed. This does not constitute investment advice.
Download the Univest iOS App or Univest Android App to track Hexagon Nutrition IPO GMP GMP updates, subscription data and listing alerts.
Should You Apply for the Hexagon Nutrition IPO GMP?
The decision to apply for the Hexagon Nutrition IPO GMP should be based on a thorough review of the company’s financials, business model, valuation, and risk factors as disclosed in the Red Herring Prospectus. The Hexagon Nutrition IPO GMP of Rs 10 provides some indication of grey market sentiment, but GMP is unofficial and can change rapidly. Investors should evaluate the Hexagon Nutrition IPO GMP valuation against listed peers, assess the promoter track record, and consider whether the business has durable competitive advantages before applying. This article is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered financial advisor before making any investment decision related to the Hexagon Nutrition IPO GMP.
Conclusion
The Hexagon Nutrition IPO GMP on 5 June 2026 is in its day 1 with subscription data and a GMP of Rs 10 (expected listing gain ~22.2%). The Hexagon Nutrition IPO GMP issue closes on June 9, 2026, with allotment expected on June 10, 2026 and listing on June 12, 2026 (BSE and NSE). Investors should review the Hexagon Nutrition IPO GMP prospectus, compare the valuation with listed peers, and make an informed decision based on their own risk appetite and investment horizon. This does not constitute investment advice.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Disclaimer: The securities quoted, if any, are for illustration purposes only and are not recommendatory. This article is for educational purposes only and shall not be considered as investment advice or a recommendation by Univest (Uniresearch Global Pvt Ltd, SEBI Registered Research Analyst INH000013776). Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI in no way guarantees the performance of the intermediary or provides any assurance of returns to investors. Past performance is not indicative of future results.
Frequently Asked Questions on Hexagon Nutrition IPO GMP
What is the Hexagon Nutrition IPO GMP today on 5 June 2026?
Ans. The Hexagon Nutrition IPO GMP today on 5 June 2026 is Rs 10 per share. Based on this GMP, the expected listing price for Hexagon Nutrition is approximately Rs 55 per share, against the upper price band of Rs 45, indicating a potential listing gain of approximately 22.2%. The Hexagon Nutrition IPO GMP reached a high of Rs 10 on June 4, having started from Rs 0 earlier in the week. Grey market premium is unofficial and unregulated by SEBI, and should be treated as one indicator of market sentiment rather than a guaranteed listing price.
What is the Hexagon Nutrition IPO price band and lot size?
Ans. The Hexagon Nutrition IPO price band is Rs 42 to Rs 45 per equity share with a face value of Rs 1 per share. The minimum lot size for the Hexagon Nutrition IPO is 333 shares. Retail investors can apply for one lot (333 shares) at the minimum investment of Rs 14,985 at the upper price band of Rs 45. For sNII (small HNI), the minimum is 14 lots (4,662 shares, Rs 2,09,790) and for bNII (big HNI) the minimum is 67 lots (22,311 shares, Rs 10,03,995). The Hexagon Nutrition IPO is a mainboard issue listed on both BSE and NSE.
When will Hexagon Nutrition IPO close and what are the key dates?
Ans. The Hexagon Nutrition IPO opened for subscription on June 5, 2026 and will close on June 9, 2026. The anchor investor allocation was conducted on June 4, 2026. The basis of allotment for the Hexagon Nutrition IPO is expected to be finalised on June 10, 2026. Shares will be credited to eligible investors’ Demat accounts on June 11, 2026, with refunds processed on the same day. The tentative listing date for Hexagon Nutrition on BSE and NSE is June 12, 2026. The registrar for the Hexagon Nutrition IPO is KFin Technologies Limited.
What does Hexagon Nutrition do?
Ans. Hexagon Nutrition Limited, founded in 1993, is one of India’s leading nutrition companies. The company operates in the nutritional ingredients and fortified food products space, serving B2B customers including food manufacturers, pharmaceutical companies, and institutional nutrition programmes. Its product portfolio includes micronutrient premixes, nutritional supplements, and fortified food ingredients. Hexagon Nutrition reported FY25 revenue of Rs 331.29 crore, up from Rs 304.62 crore in FY24 (+8.7% growth), and FY25 profit of Rs 24.38 crore, more than doubling from Rs 12.21 crore in FY24. The promoters are Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Vikram Arun Kelkar and Nikhil Arun Kelkar.
Is the Hexagon Nutrition IPO a good investment given its GMP?
Ans. The Hexagon Nutrition IPO GMP of Rs 10 (approximately 22% above the issue price of Rs 45) suggests moderately positive grey market sentiment. Positive factors include: a 22% GMP indicating expected listing premium, low minimum investment of Rs 14,985 making it accessible, FY25 profit growth of 100%+ year-on-year, and mainboard listing on both BSE and NSE improving liquidity. Risk factors include: the IPO is entirely an OFS (offer for sale), meaning all proceeds go to selling shareholders and not the company itself, which some investors view negatively as it indicates promoter monetisation at the IPO stage. The post-IPO promoter holding will come down from 89.41% to approximately 64.29%. Investors should review the RHP before applying. This does not constitute investment advice.
